FDA Inspection
Johns Hopkins Hospital Blood BankJohns Hopkins Hospital Blood Bank – FDA Inspection, Mar 10, 2011
Record Details
This FDA Inspection record concerns Johns Hopkins Hospital Blood Bank, with an inspection on March 10, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 10, 2011
- Product Type
- Biologics
View Company Profile
ID · 8bad00ca-950b-47ab-9e39-628bcaad4b0e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 713520
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.121(c)(1)Proper name of product
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Johns Hopkins Hospital Blood Bank
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2025 | VAI | Baltimore District Office | Blood and Blood Products |
| March 23, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 14, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 27, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 26, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Johns Hopkins Hospital Blood Bank
- FDA Inspection 1260819 - 2025-02-13
- FDA Inspection 1167106 - 2022-03-23
- FDA Inspection 1020993 - 2017-07-14
- FDA Inspection 916474 - 2015-02-27
- FDA Inspection 851936 - 2013-09-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.